BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND BLM, MGC131620, 641, ENSG00000197299, MGC131618, RECQ2, RECQL2, RECQL3, MGC126616, BS AND Treatment
156 results:

  • 1. Single cell analysis unveils B cell-dominated immune subtypes in HNSCC for enhanced prognostic and therapeutic stratification.
    Li K; Zhang C; Zhou R; Cheng M; Ling R; Xiong G; Ma J; Zhu Y; Chen S; Chen J; Chen D; Peng L
    Int J Oral Sci; 2024 Apr; 16(1):29. PubMed ID: 38622125
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A meta-analysis comparing efficacy and safety between proton beam therapy versus carbon ion radiotherapy.
    Jang JY; Kim K; Chen MF; Akimoto T; Wang MLC; Kim MJ; Kim K; Lee TH; Yoo GS; Park HC
    Cancer Med; 2024 Feb; 13(3):e7023. PubMed ID: 38396380
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Contrasting clinical outcomes and socio-economic impact of young versus elderly-onset oral squamous cell carcinoma, a novel health economic analysis.
    Singh M; Thankappan K; Balasubramanian D; Pillai V; Shetty V; Rangappa V; Chandrasekhar NH; Kekatpure V; Kuriakose MA; Krishnamurthy A; Mitra A; Pattatheyil A; Jain P; Iyer S; Iyer NG; Subramaniam N;
    Cancer Med; 2024 Feb; 13(3):e6747. PubMed ID: 38225902
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Tislelizumab versus chemotherapy as second-line treatment for European and North American patients with advanced or metastatic esophageal squamous cell carcinoma: a subgroup analysis of the randomized phase III RATIONALE-302 study.
    Ajani J; El Hajbi F; Cunningham D; Alsina M; Thuss-Patience P; Scagliotti GV; Van den Eynde M; Kim SB; Kato K; Shen L; Li L; Ding N; Shi J; Barnes G; Van Cutsem E
    ESMO Open; 2024 Jan; 9(1):102202. PubMed ID: 38118368
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Multi-task deep learning-based radiomic nomogram for prognostic prediction in locoregionally advanced nasopharyngeal carcinoma.
    Gu B; Meng M; Xu M; Feng DD; Bi L; Kim J; Song S
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3996-4009. PubMed ID: 37596343
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Buccal spray of standardized Berberis aristata extract causes tumour regression, chemoprotection and downregulation of inflammatory mediators in oral cancer hamster model.
    Tamane P; Mahadik K; Pokharkar V
    J Ethnopharmacol; 2023 Dec; 317():116732. PubMed ID: 37315644
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Aspirin or statin use in relation to survival after surgery for esophageal cancer: a population-based cohort study.
    Holmberg D; Gottlieb-Vedi E; Hedberg J; Lindblad M; Mattsson F; Lagergren J
    BMC Cancer; 2023 Apr; 23(1):375. PubMed ID: 37098462
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Biomarkers predicting clinical outcomes in nasopharyngeal cancer patients receiving immune checkpoint inhibitors: A systematic review and meta-analysis.
    Qian X; Chen H; Tao Y
    Front Immunol; 2023; 14():1146898. PubMed ID: 37063822
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Proton beam therapy for skull base chordomas: a systematic review of tumor control rates and survival rates.
    Pahwa B; Medani K; Lu VM; Elarjani T
    Neurosurg Rev; 2022 Dec; 45(6):3551-3563. PubMed ID: 36181614
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Sarcopenia reduces overall survival in unresectable oesophageal cancer: a systematic review and meta-analysis.
    Jogiat UM; Bédard ELR; Sasewich H; Turner SR; Eurich DT; Filafilo H; Baracos V
    J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2630-2636. PubMed ID: 36151845
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Endoscopic versus Nonendoscopic Surgery for Resection of Craniopharyngiomas.
    Abiri A; Roman KM; Latif K; Goshtasbi K; Torabi SJ; Lehrich BM; Mohyeldin A; Hsu FPK; Kuan EC
    World Neurosurg; 2022 Nov; 167():e629-e638. PubMed ID: 36041722
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Intensity modulated radiation therapy for elderly patients with esophageal cancer: Our experience.
    Li D; Liu X; Wang Y; Jin Y; Li F; Ma H
    Biomol Biomed; 2023 Mar; 23(2):327-334. PubMed ID: 36032036
    [TBL] [Abstract] [Full Text] [Related]  

  • 13.
    Wei XF; Chen XK; Lu L; Luo P; Xu L; Xie HN; Yang YF; Yu YK; Li HM; Liu Q; Zhang RX; Qin JJ; Li Y
    Thorac Cancer; 2022 Aug; 13(16):2371-2376. PubMed ID: 35811377
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Progression and postoperative complications of osteoradionecrosis of the jaw: a 20-year retrospective study of 124 non-nasopharyngeal cancer cases and meta-analysis.
    Kang Z; Jin T; Li X; Wang Y; Xu T; Wang Y; Huang Z; Huang Z
    BMC Oral Health; 2022 May; 22(1):213. PubMed ID: 35643546
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Integrative analysis of therapy resistance and transcriptomic profiling data in glioblastoma cells identifies sensitization vulnerabilities for combined modality radiochemotherapy.
    Schnöller LE; Albrecht V; Brix N; Nieto AE; Fleischmann DF; Niyazi M; Hess J; Belka C; Unger K; Lauber K; Orth M
    Radiat Oncol; 2022 Apr; 17(1):79. PubMed ID: 35440003
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The Prognostic Impact of Radiotherapy Delays in Oropharynx Carcinoma and the Role of p16 Status.
    Urban R; Alfaraj F; Olson R; Berthelet E; Tran E; Wu J; Hamm J; Hamilton S
    Am J Clin Oncol; 2022 Mar; 45(3):122-128. PubMed ID: 35081053
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Risk of depression in patients with oral cancer: a nationwide cohort study in Taiwan.
    Kung LY; Li TI; Chung CH; Lee SP; Chen GS; Chien WC; Tzeng NS
    Sci Rep; 2021 Dec; 11(1):23524. PubMed ID: 34876632
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Prediction models applying machine learning to oral cavity cancer outcomes: A systematic review.
    Adeoye J; Tan JY; Choi SW; Thomson P
    Int J Med Inform; 2021 Oct; 154():104557. PubMed ID: 34455119
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Liquid biopsy posttreatment surveillance in endemic nasopharyngeal carcinoma: a cost-effective strategy to integrate circulating cell-free Epstein-Barr virus DNA.
    Wu CF; Lin L; Mao YP; Deng B; Lv JW; Zheng WH; Wen DW; Kou J; Chen FP; Yang XL; Xu SS; Ma J; Zhou GQ; Sun Y
    BMC Med; 2021 Aug; 19(1):193. PubMed ID: 34433440
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Long-term effectiveness of lycopene in the management of oral submucous fibrosis (OSMF): A 3-years follow-up study.
    Arakeri G; Patil S; Maddur N; Rao Us V; Subash A; Patil S; Gao S; Brennan PA
    J Oral Pathol Med; 2020 Sep; 49(8):803-808. PubMed ID: 32652683
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8.